Teflaro, also known as Cecropin, is an antibiotic medication used to treat skin infections and pneumonia. It is manufactured by the pharmaceutical company Abbvie. According to DrugPatentWatch.com, Teflaro's patent expiration date is August 2020 [1]. After the patent expiration, other companies can apply for approval to produce generic versions of the drug, which can increase accessibility and potentially lower costs for consumers. It is important to note that the patent expiration date can be subject to change and may differ depending on the country or region.

Sources:
[1] <https://www.drugpatentwatch.com/drugs/teflaro>